Dimitrios Tryfonopoulos

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Germline Genetic Testing in Breast and Gynecologic Cancers: Evaluating Age at Diagnosis as a Determinant.

Germline Genetic Testing in Breast and Gynecologic Cancers: Evaluating Age at Diagnosis as a Determinant.

Journal: Cancers

Published: April 17, 2026

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study.

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study.

Journal: Cancers

Published: June 06, 2025

The Impact of Lifestyle Medicine on Quality of Life in Female Breast Cancer Survivors: A Systematic Review.

The Impact of Lifestyle Medicine on Quality of Life in Female Breast Cancer Survivors: A Systematic Review.

Journal: American journal of lifestyle medicine

Published: February 05, 2025

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study.

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study.

Journal: ESMO real world data and digital oncology

Published: January 04, 2025

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Journal: Cancers

Published: June 04, 2024

CDK4/6 and aromatase inhibitors as first-line treatment in metastatic high-grade neuroendocrine carcinoma of the breast: A case report.

CDK4/6 and aromatase inhibitors as first-line treatment in metastatic high-grade neuroendocrine carcinoma of the breast: A case report.

Journal: Clinical case reports

Published: May 03, 2024

Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study).

Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study).

Journal: BMC cancer

Published: January 24, 2024

Advancing Colorectal Cancer Diagnosis with AI-Powered Breathomics: Navigating Challenges and Future Directions.

Advancing Colorectal Cancer Diagnosis with AI-Powered Breathomics: Navigating Challenges and Future Directions.

Journal: Diagnostics (Basel, Switzerland)

Published: November 10, 2023

Genetic Predisposition to Male Breast Cancer: A Case Series.

Genetic Predisposition to Male Breast Cancer: A Case Series.

Journal: Anticancer research

Published: October 11, 2022

Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross-sectional study.

Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross-sectional study.

Journal: Oncology letters

Published: February 16, 2022

Nivolumab-induced lichenoid granulomatous stomatitis in a patient with advanced melanoma: A case report.

Nivolumab-induced lichenoid granulomatous stomatitis in a patient with advanced melanoma: A case report.

Journal: Molecular and clinical oncology

Published: November 15, 2021

AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study.

AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 18, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026